The European Union rates the GAPVAC project and Consortium as one of the recent EU research success stories! The online article highlights the results of the GAPVAC-101 phase 1 study that were recently published in Nature. Furthermore, the project is recognized as a blueprint for future personalized cancer treatments.
See the full article here.